U.S. Water Utilities Stock News

NYSE:CUBI
NYSE:CUBIBanks

Should Customers Bancorp’s US$100 Million Buyback Shift How CUBI Investors View Its Capital Priorities?

On February 11, 2026, Customers Bancorp, Inc. announced that its Board of Directors had authorized a one-year share repurchase program of up to US$100,000,000 of its common stock. This buyback authorization highlights management’s willingness to deploy capital into reducing the share count, which can enhance per-share metrics and shareholder returns over time. Now we’ll examine how this US$100,000,000 repurchase plan may reshape Customers Bancorp’s investment narrative and capital allocation...
NYSE:DX
NYSE:DXMortgage REITs

Is Dynex Capital (DX) Pricing Reflect Recent Mortgage REIT Reassessment Accurately?

If you are wondering whether Dynex Capital's current share price offers good value, you are not alone, especially with income focused investors often watching mortgage REITs closely. The stock last closed at US$14.13, with returns of 0.6% over 7 days, a 3.4% decline over 30 days, 0.4% year to date, 17.4% over 1 year, 59.2% over 3 years and 35.7% over 5 years. This raises fair questions about how that performance lines up with the underlying value. Recent coverage around Dynex Capital has...
NasdaqGS:CYTK
NasdaqGS:CYTKBiotechs

Is It Too Late To Reassess Cytokinetics (CYTK) After Its 41% One Year Gain?

If you are looking at Cytokinetics and wondering whether the current share price actually reflects its underlying value, you are not alone. The stock most recently closed at US$67.94, with returns of 2.5% over 7 days, 7.1% over 30 days, 10.1% year to date and 41.1% over the past year, which naturally raises questions about what is already priced in and what is not. Recent attention around Cytokinetics has focused on its pipeline progress and regulatory milestones, which often influence how...
NYSE:TREX
NYSE:TREXBuilding

Will Trex’s (TREX) Cooler Decking Push and Board Refresh Change Its Investment Narrative?

In February 2026, Trex Company expanded its Performance-Engineered outdoor living portfolio with cooler-running SunCom comfortable decking, new Transcend Lineage 1"x4" boards, enhanced railing options, and composite fencing, while appointing industry veteran Irene Tasi to its Board and Audit and Compensation Committees. Alongside these product launches and governance changes, Trex’s recent industry awards and sustainability rankings highlight a brand pushing innovation even as competitive...
NasdaqGS:ORIC
NasdaqGS:ORICBiotechs

ORIC Cancer Pipeline Progress And Big Pharma Partnerships Reshape Risk Profile

ORIC Pharmaceuticals (NasdaqGS:ORIC) reports progress in its cancer therapy pipeline, with lead drug candidates entering Phase 1b clinical trials. The company announces new collaborations with Pfizer, Bayer, and Johnson & Johnson, aimed at advancing therapies that target resistance mechanisms in cancer treatment. These developments are drawing increased investor attention as they represent material steps in ORIC Pharmaceuticals' clinical and partnership strategy. ORIC Pharmaceuticals...
OTCPK:DIDI.Y
OTCPK:DIDI.YTransportation

US$740 Million Class Action Settlement Review Might Change The Case For Investing In DiDi Global (DIDI.Y)

Rosen Law Firm announced that the U.S. District Court for the Southern District of New York has certified a class action and is reviewing a proposed US$740,000,000 settlement to resolve claims by DiDi Global ADS purchasers, with a hearing scheduled for June 16, 2026. If approved, this sizable settlement would cap a major legal overhang for DiDi Global, clarifying potential liabilities and closing a lengthy litigation chapter. Next, we will examine how this proposed US$740,000,000 class...
NasdaqGS:SFD
NasdaqGS:SFDFood

Assessing Smithfield Foods (SFD) Valuation After Recent Share Price Momentum

Smithfield Foods (SFD) is back on investors’ radar after recent share price moves, with the stock showing mixed short term returns but stronger performance over the past month and the past three months. See our latest analysis for Smithfield Foods. The latest share price of US$25.04 sits alongside a 30 day share price return of 10.07% and a 90 day share price return of 18.50%. The 1 year total shareholder return of 24.16% points to momentum that has been building rather than fading. If recent...
NasdaqGS:PAYX
NasdaqGS:PAYXProfessional Services

Paychex Director Buys More Shares As Valuation Flags Potential Upside

Paychex Director Joseph Doody recently acquired additional shares of NasdaqGS:PAYX, signaling increased personal exposure to the company. The insider purchase comes as Paychex shares trade at $91.24 following a 16.0% decline year to date. This transaction adds a fresh data point for investors watching insider activity at Paychex. For investors tracking Paychex, the timing of this insider buying stands out against a weaker recent share performance. The stock is at $91.24, with a 7 day return...
NasdaqGS:LBTY.A
NasdaqGS:LBTY.ATelecom

Liberty Global (LBTY.A) Is Up 15.2% After Huge 2025 Loss Despite Higher Sales - What's Changed

Liberty Global Ltd. has reported its full-year 2025 results, with sales rising to US$4,878.5 million from US$4,341.9 million, but swinging from a net income of US$1.59 billion to a very large net loss of US$7.14 billion and a basic loss per share from continuing operations of US$20.86. The combination of higher revenue and a very large reported loss raises questions about cost structure, one-off charges, and how resilient the business model really is. We’ll now consider how this sharp move...
NYSE:CNMD
NYSE:CNMDMedical Equipment

Is It Time To Reassess CONMED (CNMD) After Its Recent Share Price Rebound

If you are wondering whether CONMED's current share price reflects its true worth, this article walks through the key signals that matter for value focused investors. The stock last closed at US$45.14, with a recent return of 8.0% over 7 days and 8.4% over 30 days, set against an 11.4% return year to date and a 25.4% decline over the past year. These moves sit against a backdrop of ongoing interest in medical devices and surgical technologies. Investors are watching how companies like CONMED...
NasdaqCM:CORT
NasdaqCM:CORTPharmaceuticals

Is Corcept Therapeutics (CORT) Now An Opportunity After A Sharp 1 Year Share Price Fall?

If you are wondering whether Corcept Therapeutics at around US$34.82 is starting to look interesting on price, you are not alone. The stock has been drawing attention from investors focused on value. The share price has seen a 12.9% decline over the last 7 days, 20.8% over 30 days, 8.8% year to date and 45.2% over 1 year, even though the 3 year and 5 year returns sit at 63.4% and 38.4% respectively. Recent coverage has largely centered on ongoing developments in its pharmaceutical and...
NYSE:MKL
NYSE:MKLInsurance

What Markel Group (MKL)'s AI‑Powered Cyber Partnership With Upfort Means For Shareholders

Earlier this week, Markel Group’s insurance operations announced a collaboration with cyber risk specialist Upfort to offer eligible U.S. cyber policyholders access to Upfort Shield, an AI‑powered, multi‑layer defense platform and endpoint detection tools aimed at helping reduce cyberattack risks. This move deepens Markel’s service offering in cyber insurance by pairing coverage with embedded risk‑prevention technology for middle‑market businesses, potentially strengthening customer...
NasdaqGS:SRRK
NasdaqGS:SRRKBiotechs

Is Scholar Rock Holding (SRRK) Attractive After Strong Multi Year Share Price Gains

If you are wondering whether Scholar Rock Holding's recent share price puts it on sale or already prices in a lot of optimism, you are asking the right question for a valuation focused look at the stock. The shares recently closed at US$48.00, with returns of 4.4% over 7 days, 8.4% over 30 days, 12.1% year to date, 27.3% over 1 year, a very large gain over 3 years, and a 11.3% decline over 5 years. This naturally raises questions about how much upside or risk is now built into the...
NYSE:TMHC
NYSE:TMHCConsumer Durables

Did Taylor Morrison’s New Brand Push and US$1 Billion Buyback Just Recast TMHC’s Investment Narrative?

Taylor Morrison Home recently launched its “Homes Built for Real Life” brand platform, highlighting authentic everyday living, while also reporting full-year 2025 revenue of US$8,121.48 million and net income of US$782.5 million, alongside a larger, extended share repurchase authorization through 2027. The combination of a consumer research-driven brand aimed at millennial and Gen Z buyers and an upsized US$1,000 million buyback plan underscores how Taylor Morrison is aligning its marketing,...
NYSE:AME
NYSE:AMEElectrical

Is AMETEK (AME) Pricing In Too Much Optimism After Strong Multi Year Share Gains

If you are looking at AMETEK and wondering whether the current price really reflects its underlying worth, you are not alone. The stock last closed at US$233.51, with returns of 1.6% over 7 days, 5.8% over 30 days, 11.7% year to date, 26.3% over 1 year, 69.0% over 3 years, and 104.5% over 5 years. This naturally raises questions about how much future potential or risk is already priced in. Recent coverage around AMETEK has focused on its role in the capital goods space and how investors are...
NYSE:NVT
NYSE:NVTElectrical

nVent Elevates Supply Chain Role To Support Growth And Data Centers

nVent Electric (NYSE:NVT) appointed Mellinda Devese as Executive Vice President and Chief Supply Chain Officer. Devese joins nVent from GE HealthCare, where she held multiple global supply chain leadership roles. Her appointment signals an increased focus on supply chain performance across nVent’s global operations. nVent Electric, listed on the NYSE under ticker NVT, focuses on electrical connection and protection solutions across industrial, commercial, and infrastructure markets. Supply...
NYSE:GBX
NYSE:GBXMachinery

A Look At Greenbrier Companies (GBX) Valuation As Weak Demand And Cash Flow Concerns Pressure The Story

Recent commentary on Greenbrier Companies (GBX) has focused on two years of declining unit sales, tighter supply chain competition, high production costs that have compressed gross margins to 14%, and negative free cash flow that has heightened investor scrutiny. See our latest analysis for Greenbrier Companies. Against those headwinds, the share price has shown strong momentum, with a 16.21% 1 month share price return, a 36.01% 3 month share price return, and a 106.10% 3 year total...
NYSE:AGM
NYSE:AGMDiversified Financial

Is Federal Agricultural Mortgage (AGM) Attractive After A 26% One-Year Share Price Slide

If you are wondering whether Federal Agricultural Mortgage is starting to look like value after its recent pullback, this article will walk through what the current share price might be implying about the company. The stock last closed at US$149.46, with a 14.1% decline over 7 days, a 12.7% decline over 30 days, a 15.3% decline year to date, and a 25.8% decline over the past year, while the 3 year and 5 year returns sit at 15.9% and 103.1% respectively. Recent coverage has focused on how...
NYSE:WELL
NYSE:WELLHealth Care REITs

Is It Too Late To Consider Welltower (WELL) After A 43% One Year Surge?

Many investors are asking whether Welltower's current share price is aligned with its underlying value, or whether expectations have moved ahead of the fundamentals. The stock last closed at US$208.19, with a 1 year return of 42.6% and a 3 year return that is very large at around triple the starting point. This kind of performance can change how the market views both its growth potential and its risk profile. Recent headlines around Welltower have focused on portfolio activity, capital...
NYSE:GXO
NYSE:GXOLogistics

Is It Too Late To Consider GXO Logistics (GXO) After Its 67% One Year Rally?

Wondering if GXO Logistics is still good value after its recent run, or if you might be late to the story? This article is aimed squarely at that question. The share price recently closed at US$65.59, with returns of 0.1% over 7 days, 14.2% over 30 days, 20.8% year to date, and 66.9% over the past year. These figures naturally raise questions about growth potential and changing risk perceptions. Recent coverage has focused on GXO Logistics' position in outsourced logistics and warehouse...
NYSE:WAL
NYSE:WALBanks

Huntington Promotion Puts Focus On Western Alliance Association Banking Value

Western Alliance Bancorporation (NYSE:WAL) has promoted Craig Lee Huntington to lead its Association Banking group. Huntington is a founding member of Alliance Association Bank with experience across sales, operations, product, and technology. The promotion highlights the importance of the Association Banking unit within Western Alliance's broader business. The Association Banking group at Western Alliance Bank focuses on serving community associations and related clients, an area that...
NYSE:SEI
NYSE:SEIEnergy Services

Solaris Energy Ties AI Power Deal To New CFO And Capital Choices

Solaris Energy Infrastructure (NYSE:SEI) has signed a ten year equipment rental agreement with an affiliate of a global AI computing leader for power generation supporting data center demand. The company also announced a major finance leadership change, with a new CFO bringing restructuring and sector experience as the outgoing CFO shifts to grow the power solutions segment. Solaris Energy Infrastructure, trading at $49.24, sits at an interesting point after a 39.1% return over the past...
NYSE:ARR
NYSE:ARRMortgage REITs

ARMOUR Residential REIT Q4 Update Highlights Income Potential And Key Risks

ARMOUR Residential REIT (NYSE:ARR) reported robust Q4 2025 results, highlighting portfolio growth and higher book value. The company affirmed its dividend, signaling confidence in the stability of its payout. Management outlined updated plans for capital deployment and risk management in what it views as a supportive market backdrop. The portfolio update included a focus on lower coupon and seasoned mortgage-backed securities to address prepayment risk. ARR also raised fresh capital and...
NasdaqGS:FITB
NasdaqGS:FITBBanks

How Investors May Respond To Fifth Third Bancorp (FITB) Earnings Beat And Capital Return Plans

In recent weeks, Fifth Third Bancorp reported stronger-than-expected fourth-quarter adjusted earnings of US$1.08 per share, supported by higher net interest income, fee income, growing deposits, and lower provisions, while also outlining plans for revenue and profitability growth through 2027. Fresh analyst upgrades have underscored the bank’s solid capital position, rising dividends, disciplined credit standards, and potential for enhanced shareholder returns through future dividend growth...